We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,190.00
Bid: 6,180.00
Ask: 6,190.00
Change: -10.00 (-0.16%)
Spread: 10.00 (0.162%)
Open: 6,200.00
High: 6,210.00
Low: 6,090.00
Prev. Close: 6,200.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

19 Mar 2020 07:00

RNS Number : 6978G
4imprint Group PLC
19 March 2020
 

19 March 2020

 

4imprint Group plc ("4imprint" or the "Group")

Coronavirus (COVID-19): Update

 

In the light of the rapidly evolving situation resulting from the spread of COVID-19 and its development into a global pandemic, 4imprint today provides an update on the Group's current trading and operations.

 

Our first priority remains the health, safety and well-being of our people. This will not change. We will be informed by the latest governmental recommendations and measures and we will play our part to control the spread of COVID-19.

 

COVID-19 poses two primary threats to our business operations:

· Supply chain disruption. As noted in the Group's 2019 full year results announcement on 3 March 2020, around 60% of the blank products that we sell originate in China. In February 2020, at the height of the COVID-19 disruption in China, this part of the supply chain was a major concern. However, the timing of the inventory cycle meant that our domestic suppliers have been able to fulfil our customer orders since then. At the same time, we have closely monitored a substantial recovery of production capacity in Chinese factories. A more pressing supply concern now is the spread of COVID-19 in North America and the UK and the resulting potential restrictions on the operations of our domestic suppliers. We have very strong relationships with our suppliers and we will continue to work closely with them in the coming days and weeks as the situation evolves.

· Demand implications of global pandemic. The rapid spread of COVID-19 in North America and the UK has now begun to have a serious impact on demand in our business. In our results announcement on 3 March 2020, we noted that trading results in the first two months of 2020 were in line with the Board's expectations. To be more specific, total orders received were up more than 13% over the same period in 2019, and this level of demand activity continued through 9 March 2020. From 10 March 2020 onwards, however, we have experienced a significant reduction in daily order flow. Over this short space of time, daily order counts have been very volatile, and have fallen materially to an average over the last three trading days of around 40% of the prior year.

 

We are unable to predict how long this lower level of order activity will last, but clearly the effects of COVID-19 will impact revenue and profitability in the current financial year. In the immediate term we are materially recalibrating our marketing activities and identifying and implementing cost saving initiatives, whilst being careful not to compromise the long-term prospects of the business. We have every confidence in the flexibility and professionalism of our team members to look after our customers at this difficult time.

 

There is no historical precedent in the business for the demand reduction that we are seeing. At this point the speed and volatility of the unfolding crisis makes accurate or responsible forecasting very challenging. We are, however, actively working through models at various levels of demand and duration that will help guide our decision making. Additional guidance will be provided to the market as and when we have more clarity.

 

4imprint remains very well-financed, with a $51m cash balance at the end of February 2020 and no debt. Given the strength and market position of the business prior to the COVID-19 crisis, the Board remains confident in the ability of the team to manage the business successfully through difficult times and to protect longer-term value for all stakeholders.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/ 2014. The person who arranged the release of this announcement on behalf of 4imprint was David Seekings, Chief Financial Officer of 4imprint.

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFDFWAESSESD
Date   Source Headline
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn
19th Jul 20227:00 amRNSTrading Statement
7th Jul 20222:26 pmRNSHolding(s) in Company
24th Jun 20229:37 amRNSEBT Purchase
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company
17th May 20227:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.